Stockreport

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

Relay Therapeutics, Inc.  (RLAY) 
PDF 3 new programs include 2 genetic disease programs – vascular malformations & Fabry disease – & 1 precision oncology program – NRAS-specific inhibitor Cash guidance re [Read more]